Buyer Takeaway 6: The "hidden trade-off" language accurately reflects a gap between what GLP-1 clinical research is documenting about bone loss and lean mass reduction (2024-2025 peer-reviewed studies) and what's typically discussed at standard weight-loss follow-up appointments
The scale is moving
Konisky H, Bowe WP, Yang P, Kobets K (2023) A clinical evaluation of the efficacy and tolerability of a novel topical antioxidant formulation featuring vitamin C, astaxanthin, and fermented turmeric
This section focuses on the signaling mechanism of GLP1R in the pancreas
In the same press release, she added, GLP-1 users face specific nutritional challenges and finding products tailored to these needs can be challenging
Separate large scale clinical trials totaling over 450,000 participants demonstrate there are significant reductions in dementia incidence for individuals using GLP-1 medications based upon hazard ratio data